These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15261288)

  • 41. Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats.
    Liu X; Vilenski O; Kwan J; Apparsundaram S; Weikert R
    Drug Metab Dispos; 2009 Jul; 37(7):1548-56. PubMed ID: 19389861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation.
    Ikeda T; Kurosawa M; Uchikawa C; Kitayama S; Nukina N
    Biochem Biophys Res Commun; 2005 Feb; 327(1):218-24. PubMed ID: 15629452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
    Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
    Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum.
    Volz TJ; Bjorklund NL; Schenk JO
    Synapse; 2005 Sep; 57(3):175-8. PubMed ID: 15945061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of environmental enrichment on behavior and dopamine transporter function in medial prefrontal cortex in adult rats prenatally treated with cocaine.
    Neugebauer NM; Cunningham ST; Zhu J; Bryant RI; Middleton LS; Dwoskin LP
    Brain Res Dev Brain Res; 2004 Nov; 153(2):213-23. PubMed ID: 15527889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
    Fu XZ; Tang L; Yuan M; Shi JS
    Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909).
    Stepanov V; Järv J
    Neurochem Int; 2008 Dec; 53(6-8):370-3. PubMed ID: 18845198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of dopamine transporter and abnormal behavior in STAT6-deficient mice.
    Yukawa K; Iso H; Tanaka T; Tsubota Y; Owada-Makabe K; Bai T; Takeda K; Akira S; Maeda M
    Int J Mol Med; 2005 May; 15(5):819-25. PubMed ID: 15806304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT).
    Mochizuki H; Amano T; Seki T; Matsubayashi H; Mitsuhata C; Morita K; Kitayama S; Dohi T; Mishima HK; Sakai N
    Neurochem Int; 2005 Jan; 46(2):93-105. PubMed ID: 15627510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological activity of some known and putative duloxetine metabolites.
    Kuo F; Gillespie TA; Kulanthaivel P; Lantz RJ; Ma TW; Nelson DL; Threlkeld PG; Wheeler WJ; Yi P; Zmijewski M
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3481-6. PubMed ID: 15177457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [2-(3-Halogen-4-hydroxyphenyl)-1,4-napthoquinone derivatives from 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-analogs, potent 5-lipoxygenase inhibitors. 27. 1,4-Naphthoquinones].
    Wurm G; Schwandt S
    Pharmazie; 1999 Jul; 54(7):487-90. PubMed ID: 10445242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and synthesis of novel luteolin derivatives as DAT agonists.
    Zhang J; Liu X; Lei X; Wang L; Guo L; Zhao G; Lin G
    Bioorg Med Chem; 2010 Nov; 18(22):7842-8. PubMed ID: 20971650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fragmentation pathway of dopamine transporter ligands: N-substituted-2beta-carbomethoxy-3beta-phenylnortropane derivatives.
    Mavel S; Abarbri M; Frangin Y; Duchène A; Emond P
    J Pharm Biomed Anal; 2004 Apr; 35(1):193-8. PubMed ID: 15030894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of [18F]NNC 12-0817 and [18F]NNC 12-0818; two potential radioligands for the dopamine transporter.
    Müller L; Halldin C; Foged C; Hohlweg R
    Appl Radiat Isot; 1995 May; 46(5):323-8. PubMed ID: 7581289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antioxidative activity of some phenoxy and organophosphorous compounds.
    Bonarska D; Kleszczyńska H; Sarapuk J
    Cell Mol Biol Lett; 2002; 7(3):929-35. PubMed ID: 12378278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel (3,5-di-tert-butyl-2-hydroxy-phenylcarbamoyl)-alkanoic acids as potent antioxidants.
    Lodyato VI; Yurkova IL; Sorokin VL; Shadyro OI; Dolgopalets VI; Kisel MA
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4253-6. PubMed ID: 15261281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The antioxidant activity of individual fractions of brain tissue].
    Promyslov MSh; Demchuk ML
    Vopr Med Khim; 1993; 39(3):30-1. PubMed ID: 8333186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neuropharmacological actions of some N-phenyl piperazine derivatives (author's transl)].
    Zou G; Tu ZH; Lu RF; Jiang XJ
    Yao Xue Xue Bao; 1981 May; 16(5):321-7. PubMed ID: 6113727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.